ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

Policy Updates
Oct
27
CLSA Supports Prop. 14: Californians for Stem Cell Research, Treatments and Cures

This November, voters will have the opportunity to vote yes on Proposition 14 to authorize $5.5 billion in state general obligation bonds to continue the advancement of treatments and cures here in
California.

Category: CLSA HomeCLSA WireSacramento
Oct
23
CLSA Working to Submit Comments to CMS on Medicare Coverage of Innovative Technology (MCIT) Proposed Rule

In September, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule (CMS-3372-P) entitled “Medicare Coverage of Innovative Technology (MCIT) and Definition of ‘Reasonable and Necessary’”. 

Category: CLSA HomeCLSA WireWashington
Sep
29
Federal Appropriations Update – Continuing Resolution Likely Through Dec. 11

The new Fiscal Year (FY) will begin at midnight tonight on October 1st.  At the time this update was prepared on September 29th, a government shutdown is unlikely following the House passage of a continuing resolution (CR) to fund the government at FY20 levels through December 11, 2020. 
Category: CLSA HomeCLSA WireWashington
Sep
28
Governor Newsom Signs Bill to Protect Biomedical Research

On Friday, September 25th, Governor Newsom signed AB 713 a measure introduced by Assembly member Kevin Mullin (D-South San Francisco).
Category: CLSA HomeCLSA WireSacramento
Sep
14
CLSA Statement on “Lowering Drug Prices by Putting America First” Executive Order issued 9/13/20

CLSA is profoundly disappointed by the Administration’s decision to move forward with the flawed concept of a ‘Most Favored Nation’ policy that threatens the innovative life sciences ecosystem and patient access to cutting edge biomedical advancement.
Category: CLSA HomeCLSA WireWashington
Sep
11
CA Supreme Court Strikes Down Hearing on 2018 Ballot Tax Measure

On Wednesday September 9th, the California Supreme Court refused to hear a case brought forward by the Howard Jarvis Taxpayers Association, the California Business Roundtable and the California Business Properties Association regarding whether only a simple majority versus a supermajority vote was necessary to pass a San Francisco corporate tax ballot measure which passed in 2018.

Category: CLSA HomeCLSA WireLocal Issues
Aug
31
What’s on The Ballot? Here’s A Look at California’s 2020 Propositions

While much of the attention in November’s election is focused on the race for President, Californians are going to have a lot of other decisions to make, including statewide ballot measures.

Category: CLSA HomeCLSA WireSacramento
Aug
28
The California legislature was rocked by a new round of positive COVID tests last week

A member of the Senate tested positive, requiring the entire body to be tested and cleared before they could safely continue their work.  
Category: CLSA HomeCLSA WireSacramento
Aug
16
CLSA Joins PFID Letters on AMR

CLSA has long supported efforts to combat AMR, and in a continuation of efforts to expand the coalition of organizations that CLSA engages with on important issues, we agreed to join 14 other cosigners on the letters.
Category: CLSA HomeCLSA WireWashington
Jul
29
White House Issues Executive Orders Impacting the Life Sciences

President Trump officially signed four Executive Orders (EOs) last Friday. The EOs target four policy areas: drug importation, 340B, rebate rule, and most concerning – IPI/Most Favored Nation (MFN).
Category: CLSA HomeCLSA WireWashington
MENU